Evidence map›Paper›PMID 35012343›Full record

ArticlemBio2022

Coronaviruses Nsp5 Antagonizes Porcine Gasdermin D-Mediated Pyroptosis by Cleaving Pore-Forming p30 Fragment.

Fushan Shi, Qian Lv, Tingjun Wang, Jidong Xu, Wei Xu, Yuhua Shi, Xinyu Fu, Tianming Yang, Yang Yang, Lenan Zhuang and 3 more

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. The gasdermin family: from pyroptosis mechanisms to therapeutic targets.Signal transduction and targeted therapy · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. The gasdermin family: emerging therapeutic targets in diseases.Signal transduction and targeted therapy · 2024
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Fushan Shi *Department of Veterinary Medicine, College of Animal Sciences, Zhejiang Universitygrid.13402.34, Hangzhou, Zhejiang, China.
Qian Lv *Department of Veterinary Medicine, College of Animal Sciences, Zhejiang Universitygrid.13402.34, Hangzhou, Zhejiang, China.
Tingjun WangDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang Universitygrid.13402.34, Hangzhou, Zhejiang, China.
Jidong XuDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang Universitygrid.13402.34, Hangzhou, Zhejiang, China.
Wei XuDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang Universitygrid.13402.34, Hangzhou, Zhejiang, China.ORCID 0000-0002-1287-4552
Yuhua ShiDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang Universitygrid.13402.34, Hangzhou, Zhejiang, China.
Xinyu FuDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang Universitygrid.13402.34, Hangzhou, Zhejiang, China.
Tianming YangDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang Universitygrid.13402.34, Hangzhou, Zhejiang, China.
Yang YangKey Laboratory of Applied Technology on Green-Eco-Healthy Animal Husbandry of Zhejiang Province, Zhejiang Provincial Engineering Laboratory for Animal Health Inspection & Internet Technology, College of Animal Science and Technology & College of Veterinary Medicine of Zhejiang A&F University, Hangzhou, Zhejiang, China.
Lenan ZhuangDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang Universitygrid.13402.34, Hangzhou, Zhejiang, China.
Weihuan FangDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang Universitygrid.13402.34, Hangzhou, Zhejiang, China.ORCID 0000-0002-2460-0743
Jinyan GuDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang Universitygrid.13402.34, Hangzhou, Zhejiang, China.ORCID 0000-0002-9763-9569
Xiaoliang LiDepartment of Veterinary Medicine, College of Animal Sciences, Zhejiang Universitygrid.13402.34, Hangzhou, Zhejiang, China.ORCID 0000-0002-2058-7764
Zhejiang University · CNSanya University · CNZhejiang A & F University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronaviruses (CoVs) are a family of RNA viruses that typically cause respiratory, enteric, and hepatic diseases in animals and humans. Here, we use porcine epidemic diarrhea virus (PEDV) as a model of CoVs to illustrate the reciprocal regulation between CoV infection and pyroptosis. For the first time, we elucidate the molecular mechanism of porcine gasdermin D (pGSDMD)-mediated pyroptosis and demonstrate that amino acids R238, T239, and F240 within pGSDMD-p30 are critical for pyroptosis. Furthermore, 3C-like protease Nsp5 from SARS-CoV-2, MERS-CoV, PDCoV, and PEDV can cleave pGSDMD at the Q193-G194 junction to produce two fragments unable to trigger pyroptosis. The two cleaved fragments could not inhibit PEDV replication. In addition, Nsp5 from SARS-CoV-2 and MERS-CoV also cleave human GSDMD (hGSDMD). Therefore, we provide clear evidence that PEDV may utilize the Nsp5-GSDMD pathway to inhibit pyroptosis and, thus, facilitate viral replication during the initial period, suggesting an important strategy for the coronaviruses to sustain their infection.

Indexed as

COVID-19Porcine epidemic diarrhea virusAnimalsCoronavirus 3C ProteasesGasderminsHumansPeptide HydrolasesPyroptosisSARS-CoV-2Swine3C-like proteinase, SARS-CoV-2Coronavirus 3C ProteasesGasderminsPeptide HydrolasescoronavirusGSDMDNsp5pyroptosis

Identifiers

PMID35012343
PMCPMC8749417
OpenAlexW4205572383

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.